Matches in Wikidata for { <http://www.wikidata.org/entity/Q66078549> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q66078549 description "clinical trial" @default.
- Q66078549 description "ensayu clínicu" @default.
- Q66078549 description "klinisch onderzoek" @default.
- Q66078549 description "клінічне випробування" @default.
- Q66078549 name "Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)" @default.
- Q66078549 name "Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)" @default.
- Q66078549 type Item @default.
- Q66078549 label "Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)" @default.
- Q66078549 label "Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)" @default.
- Q66078549 prefLabel "Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)" @default.
- Q66078549 prefLabel "Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)" @default.
- Q66078549 P1050 Q66078549-AC26EA8A-6B5E-4BBD-8458-23CF8AC27392 @default.
- Q66078549 P1132 Q66078549-691C38C4-DB25-461F-94C2-330EA20F4E0A @default.
- Q66078549 P1476 Q66078549-87418B1D-C1FF-400A-B406-154174D9C961 @default.
- Q66078549 P17 Q66078549-05532F84-3A22-4150-B500-E08D8648B3FB @default.
- Q66078549 P17 Q66078549-1780742F-96C6-42DD-B193-0771CFC3A892 @default.
- Q66078549 P17 Q66078549-3223D29B-4588-40AF-8ED7-DBAD094352ED @default.
- Q66078549 P17 Q66078549-4B96D294-E0DE-4A54-99C4-57EE620A25C0 @default.
- Q66078549 P17 Q66078549-5BF5D150-2A83-4834-A314-0D2758920A9F @default.
- Q66078549 P17 Q66078549-95118D85-9C23-4458-9653-B1369920F667 @default.
- Q66078549 P17 Q66078549-BF3BE4EF-2555-483F-AD1A-85936B1FEDA5 @default.
- Q66078549 P1813 Q66078549-D26AFA13-62CB-4367-988E-7FB64F4257CB @default.
- Q66078549 P2899 Q66078549-CC9DF1F9-B3B8-4D40-B0D5-ADCDC89309EF @default.
- Q66078549 P3098 Q66078549-361398DE-9EE1-4466-8A13-D541A2D38DF3 @default.
- Q66078549 P31 Q66078549-58FA89CA-C0BE-47C9-AF34-DB6DC744204A @default.
- Q66078549 P4844 Q66078549-4C85F3FD-B765-42FC-9D73-E3D7360042A9 @default.
- Q66078549 P4844 Q66078549-6AF1360A-1C5F-44DB-8BB4-DC1A5614DCBE @default.
- Q66078549 P580 Q66078549-A8BE45C9-5A83-465F-A11B-F3872BC01D9B @default.
- Q66078549 P582 Q66078549-40204B0D-59B1-41ED-9085-74EAEEC1D284 @default.
- Q66078549 P6099 Q66078549-A1FF1C63-C39E-4ACF-9D83-682F6C0CD793 @default.
- Q66078549 P6153 Q66078549-112C9E6E-9C60-4142-83B6-881777C6B477 @default.
- Q66078549 P6153 Q66078549-45D22C09-3312-488B-9421-A415ECBD5CED @default.
- Q66078549 P6153 Q66078549-51EF7712-3F87-4F5B-B43D-D37CB623588A @default.
- Q66078549 P6153 Q66078549-64D2E1ED-B748-4FDC-9D50-15EC665D8660 @default.
- Q66078549 P6153 Q66078549-6A1C2463-8FD0-441F-9ED4-166AFF244C5D @default.
- Q66078549 P6153 Q66078549-87BD8797-0F76-43C3-B735-BB5219663CE2 @default.
- Q66078549 P6153 Q66078549-9247B63F-54E9-4DDF-A0EA-9F5228A4C151 @default.
- Q66078549 P6153 Q66078549-A8C81CDB-BD12-43B4-A586-5E5267A08E7B @default.
- Q66078549 P6153 Q66078549-CF011668-790D-41DC-8428-0CED473FEB2D @default.
- Q66078549 P6153 Q66078549-E4562657-E918-4334-8FE7-DB32B3470ABE @default.
- Q66078549 P6153 Q66078549-E62BDD6F-D161-477F-9547-71F5E5531690 @default.
- Q66078549 P8363 Q66078549-6452FA54-919F-4404-B291-E357854246CC @default.
- Q66078549 P1050 Q208414 @default.
- Q66078549 P1132 "+29" @default.
- Q66078549 P1476 "PHASE 1B/PHASE 3 MULTICENTER STUDY OF AVELUMAB (MSB0010718C) IN COMBINATION REGIMENS THAT INCLUDE AN IMMUNE AGONIST, EPIGENETIC MODULATOR, CD20 ANTAGONIST AND/OR CONVENTIONAL CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) JAVELIN DLBCL" @default.
- Q66078549 P17 Q145 @default.
- Q66078549 P17 Q29 @default.
- Q66078549 P17 Q30 @default.
- Q66078549 P17 Q31 @default.
- Q66078549 P17 Q36 @default.
- Q66078549 P17 Q38 @default.
- Q66078549 P17 Q408 @default.
- Q66078549 P1813 "Javelin DLBCL" @default.
- Q66078549 P2899 "+18" @default.
- Q66078549 P3098 "NCT02951156" @default.
- Q66078549 P31 Q30612 @default.
- Q66078549 P4844 Q27272066 @default.
- Q66078549 P4844 Q412323 @default.
- Q66078549 P580 "2016-12-16T00:00:00Z" @default.
- Q66078549 P582 "2019-06-16T00:00:00Z" @default.
- Q66078549 P6099 Q42824827 @default.
- Q66078549 P6153 Q1130172 @default.
- Q66078549 P6153 Q1193547 @default.
- Q66078549 P6153 Q1920549 @default.
- Q66078549 P6153 Q230492 @default.
- Q66078549 P6153 Q33122159 @default.
- Q66078549 P6153 Q3803602 @default.
- Q66078549 P6153 Q5110676 @default.
- Q66078549 P6153 Q5902584 @default.
- Q66078549 P6153 Q598841 @default.
- Q66078549 P6153 Q624119 @default.
- Q66078549 P6153 Q833670 @default.
- Q66078549 P8363 Q78089383 @default.